AKT1 and cervical cancer: To explore the mechanism underlying PAK4-induced cisplatin resistance in cervical cancer cells, we examined the activation of PI3K/Akt pathway in the cisplatin-treated Hela and Caski cells, with or without the transfection with siRNA-PAK4 or siRNA-Con.